BioSET Prefix Study

This study is designed to evaluate the safety and preliminary effectiveness of one coating concentration of Prefix compared to iliac crest bone in approximately 22 skeletally mature subjects diagnosed with degenerative disc disease (DDD) at one vertebral level (L2-S1).

Sponsor(s)
Biosurface Engineering Technologies, Inc. (BioSET)
Principal Investigator(s)
Joseph O'Brien MD
Request Information
Address

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

3 + 11 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.